Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | lamin A/C | Starlite/ChEMBL | No references |
Homo sapiens | lysine (K)-specific demethylase 4A | Starlite/ChEMBL | No references |
Homo sapiens | G protein-coupled receptor 55 | Starlite/ChEMBL | No references |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Onchocerca volvulus | 0.0183 | 0.3435 | 0.3221 | |
Schistosoma mansoni | jumonji/arid domain-containing protein | 0.0043 | 0.0523 | 0.0216 |
Leishmania major | adenine aminohydrolase | 0.0498 | 1 | 1 |
Trichomonas vaginalis | adenosine deaminase, putative | 0.0498 | 1 | 0.5 |
Trichomonas vaginalis | adenosine deaminase, putative | 0.0498 | 1 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0316 | 0.6203 | 0.6203 |
Leishmania major | AMP deaminase, putative,amp deaminase-like protein | 0.0237 | 0.4563 | 0.1719 |
Leishmania major | adenosine monophosphate deaminase, putative,AMP deaminase, putative | 0.0237 | 0.4563 | 0.1719 |
Loa Loa (eye worm) | PHD-finger family protein | 0.0035 | 0.0369 | 0.0369 |
Echinococcus granulosus | Transcription factor JmjC domain containing protein | 0.0115 | 0.2035 | 0.1777 |
Schistosoma mansoni | adenosine deaminase-related | 0.0498 | 1 | 1 |
Leishmania major | AMP deaminase, putative,adenosine monophosphate deaminase-like protein | 0.0237 | 0.4563 | 0.1719 |
Plasmodium falciparum | AMP deaminase, putative | 0.0237 | 0.4563 | 0.4355 |
Echinococcus multilocularis | adenosine deaminase | 0.0498 | 1 | 1 |
Brugia malayi | adenosine monophosphate deaminase | 0.0237 | 0.4563 | 0.4563 |
Brugia malayi | Bromodomain containing protein | 0.0035 | 0.0369 | 0.0369 |
Loa Loa (eye worm) | hypothetical protein | 0.0316 | 0.6203 | 0.6203 |
Loa Loa (eye worm) | hypothetical protein | 0.0316 | 0.6203 | 0.6203 |
Schistosoma mansoni | AMP deaminase | 0.0237 | 0.4563 | 0.4387 |
Echinococcus multilocularis | lysine specific demethylase 5A | 0.0043 | 0.0523 | 0.0216 |
Mycobacterium tuberculosis | Probable adenosine deaminase Add (adenosine aminohydrolase) | 0.0498 | 1 | 0.5 |
Echinococcus multilocularis | jumonji domain containing protein | 0.0049 | 0.0656 | 0.0353 |
Echinococcus granulosus | peregrin | 0.0035 | 0.0369 | 0.0057 |
Echinococcus granulosus | adenosine deaminase | 0.0498 | 1 | 1 |
Trypanosoma cruzi | adenosine monophosphate deaminase-like protein, putative | 0.0237 | 0.4563 | 1 |
Giardia lamblia | PHD finger protein 15 | 0.0035 | 0.0369 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0316 | 0.6203 | 0.6203 |
Loa Loa (eye worm) | hypothetical protein | 0.006 | 0.0892 | 0.0892 |
Trypanosoma cruzi | adenosine monophosphate deaminase, putative | 0.0237 | 0.4563 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0035 | 0.0369 | 0.0369 |
Echinococcus granulosus | lysine specific demethylase 5A | 0.0043 | 0.0523 | 0.0216 |
Loa Loa (eye worm) | jmjC domain-containing protein | 0.0073 | 0.1149 | 0.1149 |
Treponema pallidum | adenosine deaminase | 0.0498 | 1 | 0.5 |
Toxoplasma gondii | Adenosine/AMP deaminase domain-containing protein | 0.0498 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0054 | 0.0766 | 0.0766 |
Brugia malayi | intermediate filament protein | 0.0033 | 0.0314 | 0.0314 |
Schistosoma mansoni | bromodomain-containing nuclear protein 1 brd1 | 0.0035 | 0.0369 | 0.0057 |
Loa Loa (eye worm) | hypothetical protein | 0.0032 | 0.0302 | 0.0302 |
Onchocerca volvulus | Alhambra homolog | 0.0035 | 0.0369 | 0.0057 |
Onchocerca volvulus | Adenosine deaminase homolog | 0.0498 | 1 | 1 |
Loa Loa (eye worm) | intermediate filament protein | 0.0033 | 0.0314 | 0.0314 |
Echinococcus multilocularis | Transcription factor, JmjC domain containing protein | 0.0115 | 0.2035 | 0.1777 |
Trypanosoma brucei | AMP deaminase, putative | 0.0237 | 0.4563 | 0.5 |
Echinococcus multilocularis | peregrin | 0.0035 | 0.0369 | 0.0057 |
Onchocerca volvulus | AMP deaminase 2 homolog | 0.0237 | 0.4563 | 0.4387 |
Plasmodium falciparum | adenosine deaminase | 0.0498 | 1 | 1 |
Trypanosoma cruzi | AMP deaminase, putative | 0.0237 | 0.4563 | 1 |
Trypanosoma cruzi | AMP deaminase, putative | 0.0237 | 0.4563 | 1 |
Brugia malayi | jmjC domain containing protein | 0.0115 | 0.2035 | 0.2035 |
Loa Loa (eye worm) | jmjC domain-containing protein | 0.0043 | 0.0523 | 0.0523 |
Trypanosoma cruzi | AMP deaminase, putative | 0.0237 | 0.4563 | 1 |
Entamoeba histolytica | adenosine deaminase, putative | 0.0498 | 1 | 1 |
Leishmania major | AMP deaminase, putative | 0.0237 | 0.4563 | 0.1719 |
Brugia malayi | jmjC domain containing protein | 0.0043 | 0.0523 | 0.0523 |
Loa Loa (eye worm) | hypothetical protein | 0.0498 | 1 | 1 |
Toxoplasma gondii | Adenosine/AMP deaminase domain-containing protein | 0.0498 | 1 | 1 |
Echinococcus granulosus | PHD finger protein rhinoceros | 0.0035 | 0.0369 | 0.0057 |
Echinococcus multilocularis | AMP deaminase 2 | 0.0237 | 0.4563 | 0.4387 |
Trypanosoma brucei | AMP deaminase, putative | 0.0237 | 0.4563 | 0.5 |
Trypanosoma cruzi | AMP deaminase, putative | 0.0237 | 0.4563 | 1 |
Schistosoma mansoni | jumonji domain containing protein | 0.0092 | 0.1542 | 0.1268 |
Loa Loa (eye worm) | hypothetical protein | 0.0183 | 0.3435 | 0.3435 |
Plasmodium vivax | adenosine deaminase, putative | 0.0498 | 1 | 1 |
Trypanosoma brucei | AMP deaminase, putative | 0.0237 | 0.4563 | 0.5 |
Entamoeba histolytica | adenosine deaminase, putative | 0.0498 | 1 | 1 |
Trypanosoma cruzi | AMP deaminase, putative | 0.0237 | 0.4563 | 1 |
Echinococcus multilocularis | PHD finger protein rhinoceros | 0.0035 | 0.0369 | 0.0057 |
Echinococcus granulosus | AMP deaminase 2 | 0.0237 | 0.4563 | 0.4387 |
Plasmodium vivax | adenosine/AMP deaminase, putative | 0.0237 | 0.4563 | 0.4355 |
Loa Loa (eye worm) | intermediate filament tail domain-containing protein | 0.0033 | 0.0314 | 0.0314 |
Schistosoma mansoni | adenosine deaminase | 0.0498 | 1 | 1 |
Echinococcus granulosus | jumonji domain containing protein | 0.0049 | 0.0656 | 0.0353 |
Toxoplasma gondii | AMP deaminase | 0.0237 | 0.4563 | 0.4355 |
Mycobacterium ulcerans | adenosine deaminase | 0.0498 | 1 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0033 | 0.0314 | 0.0314 |
Loa Loa (eye worm) | AMP deaminase | 0.0237 | 0.4563 | 0.4563 |
Mycobacterium leprae | Probable adenosine deaminase Add (ADENOSINE AMINOHYDROLASE) | 0.0498 | 1 | 0.5 |
Trypanosoma brucei | adenosine monophosphate deaminase, putative | 0.0237 | 0.4563 | 0.5 |
Schistosoma mansoni | jumonji/arid domain-containing protein | 0.0043 | 0.0523 | 0.0216 |
Brugia malayi | Intermediate filament tail domain containing protein | 0.0033 | 0.0314 | 0.0314 |
Schistosoma mansoni | hypothetical protein | 0.0035 | 0.0369 | 0.0057 |
Brugia malayi | PHD-finger family protein | 0.0035 | 0.0369 | 0.0369 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (functional) | = 2.159956 uM | PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists for GPR55. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2026, AID2809, AID2814, AID2815, AID2820, AID2822, AID2835, AID2836, AID485277, AID485278, AID485282, AID485283, AID485285, AID485286, AID485287, AID488947] | ChEMBL. | No reference |
Potency (functional) | 4.6535 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | 14.7157 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | = 15.8489 um | PUBCHEM_BIOASSAY: qHTS Assay for Modulators of Lamin A Splicing. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 19.9526 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of JMJD2A-Tudor Domain. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504402] | ChEMBL. | No reference |
Potency (functional) | = 25.1189 um | PUBCHEM_BIOASSAY: qHTS Assay for the Inhibitors of L3MBTL1. (Class of assay: confirmatory) [Related pubchem assays: 485292 (Probe Development Summary for Inhibitors of L3MBTL1)] | ChEMBL. | No reference |
Potency (functional) | 25.1189 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b: Cytotox Counterscreen. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588855, AID588860] | ChEMBL. | No reference |
Potency (functional) | 28.1838 uM | PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 31.6228 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay; Stimulation with EGF. (Class of assay: confirmatory) [Related pubchem assays: 995 ] | ChEMBL. | No reference |
Potency (functional) | = 39.8107 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Bacillus subtilis Sfp phosphopantetheinyl transferase (PPTase). (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 39.8107 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of BAZ2B. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504391] | ChEMBL. | No reference |
Potency (functional) | 89.1251 uM | PUBCHEM_BIOASSAY: HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488962] | ChEMBL. | No reference |
Potency (functional) | 112.2018 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Iota. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588623] | ChEMBL. | No reference |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Plasmodium falciparum | ChEMBL23 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.